Empowering appropriate antimicrobial use with rapid diagnostics.

Rapid Diagnostics and Antimicrobial Stewardship

By supplying healthcare providers with a comprehensive set of diagnostic information, Alere empowers a shift in prescribing behavior away from the over-use of antibiotics, which spawned the growing prevalence of serious healthcare-associated infections like MRSA and C. difficile associated disease. 

Alere offers a best-in-class rapid diagnostic which enables healthcare practitioners to distinguish between respiratory tract infections that require treatment and those that are self-limiting as well as several other diagnostic tools that can help clinicians identify pathogens at the point of care and define an appropriate treatment strategy earlier. 

These include solutions for Strep A, Influenza, S. pneumoniae, MRSA and C. difficile.

C-reactive Protein

Lower respiratory tract infection (LRTI) is one of the most common acute reasons for patients to seek medical assessment, accounting for 17 million consultations in the European Union and 11 million in the U.S. each year.1

Strep A Pharyngitis 

Acute pharyngitis constitutes a frequent cause of visits and prescribing of antibiotics in primary healthcare facilities.1


Each year, influenza (flu) causes serious infection and death around the globe, usually in the winter months (seasonal influenza).


Respiratory Syncytial Virus (RSV) is the most common cause of both severe respiratory illness such as bronchiolitis (inflammation of the bronchioles) in young children.

Pneumococcal Pneumonia 

Community-Acquired Pneumonia (CAP) is a common disease that is associated with considerable mortality and morbidity, and accounts for high antibiotic consumption.1

Legionnaires’ Disease 

Since 1977, Legionella pneumophila has been increasingly recognized as a cause of sporadic and epidemic community-acquired pneumonia (CAP) in all age groups.1


Worldwide, it is estimated that between 2-53 million people carry Methicillin-resistant Staphylococcus aureus (MRSA) and rates are increasing rapidly.

C. difficile 

Healthcare Associated Infections (HAIs) are a global concern causing significant mortality and morbidity as well as spiralling healthcare costs worldwide.

Verotoxigenic E. coli 

Vero-cytotoxin / Shiga Toxin-producing Escherichia coli (VTEC/STEC) are a significant threat to public health causing mortality worldwide.



Malaria is a preventable and treatable infectious disease transmitted by mosquitoes that kills more than one million people each year.